书目名称 | Enzyme-Prodrug Strategies for Cancer Therapy | 编辑 | Roger G. Melton,Richard J. Knox | 视频video | | 图书封面 |  | 描述 | Antibody-directed enzyme prodrug therapy (ADEPT) directlyaddresses the major problem in cancer chemotherapy-its lack ofselectivity. Antibody delivery combined with the amplificationprovided by the enzymatic activation of prodrugs enables selection tobe made between tumour and normal tissue. ADEPT offers a novel fieldof opportunities in the therapy of systemic cancer and may be a majoradvance for the treatment of solid tumours..This book is the first to describe ADEPT in detail. Each chapterreviews an aspect of the immunology, enzymology, biochemistry,chemistry, and cancer chemotherapy which have been integrated into theADEPT concept. An additional chapter describes the related approach ofgene-directed enzyme prodrug therapy (GDEPT). This latter approach isstill in its infancy but ADEPT has entered the clinic. The initialclinical studies with ADEPT are included and discussed in detail. | 出版日期 | Book 1999 | 关键词 | biochemistry; cancer; chemistry; chemotherapy; enzyme; enzymes; immunology; protein; proteins; synthesis; tiss | 版次 | 1 | doi | https://doi.org/10.1007/978-1-4615-4823-2 | isbn_softcover | 978-1-4613-7186-1 | isbn_ebook | 978-1-4615-4823-2 | copyright | Springer Science+Business Media New York 1999 |
The information of publication is updating
|
|